Vendor, Metairie, LA
28BIO, Inc.
UEI RT13MNMRHL33, CAGE 75TQ1
1 award and $143,021 obligated between July 22, 2026 and July 22, 2026, 0% under full and open competition, against 1.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- CNS Organoid Neuropharmacological Analysis
Food and Drug Administration, FDA Office of Acq Grant SVCS
Combined synopsis and solicitationNAICS 54138075F40126Q134171Awarded to 28BIO, Inc.
Posted Jun 222 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126P00150Purchase Order, July 22, 2026, Not Competed Under SAP, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | Central Nervous System (Cns)-3d Brain Organoids Neuropharmacological Analysis Eo 14398NAICS 541380, PSC B537 | $143,021 |
- Places of performance
- Louisiana
- Product and service codes
- B537 Medical and Health Studies
- Transactions
- 1 across 1 awards